Seres Therapeutics, Inc. Uncategorized Contracts & Agreements
10 Contracts & Agreements
- Employee Support Agreement, dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Filed With SEC on October 1, 2024)
- Cross-License Agreement, dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Filed With SEC on October 1, 2024)
- Form of Cross-License Agreement, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A (Filed With SEC on August 6, 2024)
- Form of Employee Support Agreement, by and between Seres Therapeutics, Inc. and Socit des Produits Nestl S.A (Filed With SEC on August 6, 2024)
- Long Term Manufacturing Agreement, dated November 8, 2021, by and between the Registrant and BacThera AG (Filed With SEC on March 1, 2022)
- Letter Agreement, dated November 4, 2021, by and between the Registrant and David S. Ege, Ph.D (Filed With SEC on November 10, 2021)
- Letter Agreement dated October 30, 2018, by and between the Registrant and Nestec Ltd (Filed With SEC on March 6, 2019)
- Seres Health,Inc. / 161 First Street Suite 1A / Cambridge, MA 02142 (Filed With SEC on June 24, 2015)
- SERES THERAPEUTICS, INC. (Filed With SEC on June 16, 2015)
- SERES HEALTH, INC. 2012 STOCKINCENTIVE PLAN (Filed With SEC on May 27, 2015)
